About Wallace Pharmaceuticals Private Limited
Data last updated:
Wallace Pharmaceuticals Private Limited is a private limited company based in Goa, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 February 1968 and has been in existence for over 58 years.
The company is registered with the Registrar of Companies (ROC), Goa, under CIN U24239GA1968PTC000080. Its GSTIN is 30AAACW1667Q1Z1 (Goa). The company holds 29 GST registrations, of which 23 are active.
The company has an authorised share capital of ₹5.5 Cr and a paid-up capital of ₹2.65 Cr. It was formerly known as Carter Wallace Private Limited and Carter Wallace Limited. It is led by directors including Rashmi Menezes (Managing Director) and Cesar Mauricio Jose De Menezes (Managing Director).
Its last annual general meeting (AGM) was held on 29 October 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 3rd Floor Dtc Building Patto Plaza Edc Complex Panaji, Goa, India – 403001.
As per the financials filed for FY 2025, the company reported a revenue of ₹673.06 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹104.4 Cr (net margin 15.5%) and EBITDA of ₹179.48 Cr (EBITDA margin 26.7%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 9% over five years.
The company has about 1,788 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹45 Cr and satisfied charges of ₹208.79 Cr on record. Court records list 161 cases involving the company, including 112 filed by the company and 51 filed against it; 47 cases are pending. The company has 5 deals on record (5 secondary share transfers); the latest was in March 2019. Its 9 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Pritam International Private Limited with revenue of ₹758.46 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wallacepharma.com.
Company details
Name history
Wallace Pharmaceuticals has undergone 3 name changes throughout its history. The company was previously known as Carter Wallace Private Limited, Carter Wallace Limited, and Wallace Pharmaceuticals Limited. The current legal name is Wallace Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Wallace Pharmaceuticals Private Limited | Current |
| Carter Wallace Private Limited | Previous |
| Carter Wallace Limited | Previous |
| Wallace Pharmaceuticals Limited | Previous |
Contact details
Wallace Pharmaceuticals Private Limited's registered office is in Goa. Its website is wallacepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address3rd Floor Dtc Building Patto Plaza Edc Complex Panaji, Goa, India – 403001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Wallace Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Wallace Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Wallace Pharmaceuticals Private Limited, buy the company report.
Financials of Wallace Pharmaceuticals Private Limited
FY 2024 filings availableWallace Pharmaceuticals Private Limited reported revenue of ₹673.06 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 16% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹179.48 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹104.4 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26.7% | ||||
| Net Profit Margin | 15.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wallace Pharmaceuticals Private Limited, buy the company report.
Board of directors of Wallace Pharmaceuticals Private Limited
Wallace Pharmaceuticals has 7 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajashekhar Rayanagoudar Basanagouda | Whole-Time Director | 01 Feb 2025 | 1 Years 8 Months | Current |
| Vinay Pinto | Director | 25 Feb 2002 | 24 Years 7 Months | Current |
| Rashmi Menezes | Managing Director | 31 May 2001 | 25 Years 4 Months | Current |
| Pankaj Kumar | Director | 22 Jun 2020 | 6 Years 4 Months | Current |
| Maria Emilia Dias Menezes | Director | 09 Dec 1997 | 28 Years 10 Months | Current |
| Cesar Mauricio Jose De Menezes | Managing Director | 15 Jun 2005 | 21 Years 4 Months | Current |
Peer comparison
Wallace Pharmaceuticals Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pritam International Private Limited | ₹758.46 Cr (FY 2025) | 15.0% | Kolkata, West Bengal, India | |||
| Indchemie Health Specialities Private Limited | ₹734.44 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Sanofi-Synthelabo (India) Private Limited | ₹729.49 Cr (FY 2020) | 16.0% | Mumbai, Maharashtra, India | |||
| Apotex Research Private Limited | ₹727.34 Cr (FY 2025) | 22.0% | Jigani Hobli, Karnataka, India | |||
| Servier India Private Limited | ₹685.38 Cr (FY 2025) | 35.0% | Mumbai, Maharashtra, India | |||
| Wallace Pharmaceuticals Private Limitedthis company | ₹673.06 Cr (FY 2025) | ₹104.4 Cr | 15.5% | 16.0% | 1,788 | Goa, India |
| Baxter Pharmaceuticals India Private Limited | ₹671.53 Cr (FY 2025) | 20.0% | Vasana Chacharwadi, Gujarat, India | |||
| Venus Remedies Limited | ₹668.84 Cr (FY 2025) | 9.0% | Chandigarh, India | |||
| Tablets (India) Ltd | ₹667.39 Cr (FY 2025) | 9.0% | Chennai, Tamil Nadu, India | |||
| RPG Life Sciences Limited | ₹666.11 Cr (FY 2025) | 13.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Wallace Pharmaceuticals Private Limited, buy the company report.
Auditor
Wallace Pharmaceuticals Private Limited is audited by Y. N. Upadhyaya & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Y. N. Upadhyaya & Co. | FY 2023 | 111173W |
Shareholding
The shareholding of Wallace Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Wallace Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Mar 2016 | 100022627 | Yes Bank Limited | ₹45 Cr | Open | |
| 28 Sep 2023 | 100791627 | Yes Bank Limited | ₹100 Cr | Satisfied | |
| 31 Mar 1999 | 90065534 | Bank of Baroda | ₹2 Cr | Satisfied | |
| 21 Jan 1999 | 90065533 | Bank of Baroda | ₹20 Lakh | Satisfied | |
| 21 Jan 1999 | 80001351 | Bank of Baroda | ₹18.5 Lakh | Satisfied |
To see the full charge records of Wallace Pharmaceuticals Private Limited, buy the company report.
Total charge records: 14 View all charges
Deals & funding
Wallace Pharmaceuticals Private Limited has 5 deals on record (5 secondary share transfers); the latest was in March 2019.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2019 | Secondary share transfer | Undisclosed | Seller: 3 individuals |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Jan 2018 | Secondary share transfer | Undisclosed | Seller: 3 individuals |
| Jan 2017 | Secondary share transfer | Undisclosed | Seller: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Wallace Pharmaceuticals Private Limited has 161 court cases on record: 112 filed by Wallace Pharmaceuticals, 51 filed against it. 47 cases are pending and 114 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 90 | 24 | 34 |
| District courts | 68 | 26 | 13 |
| Supreme Court | 3 | 1 | 0 |
Cases on record (5 of 161)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (CRR) | Filed by the company against Leegaze Pharmaceuticals Pvt Ltd and Ors. | Pending |
| Bombay High Court | Court case (CRR) | Filed by the company against Biocordis Pharmaceuticals Pvt Ltd | Pending |
| Bombay High Court | Court case (LPETN) | Filed by the company against Leegaze Pharmaceuticals Pvt Ltd | Pending |
| Bombay High Court | Court case (LPETN) | Filed by the company against Biocordis Pharmaceuticals Pvt Ltd and 1 other | Pending |
| District court, East Godavari, Andhra Pradesh | Civil suit | Filed against the company by M/S. Sri Ramadas Motor Transport Ltd., Rep. by Its Transport Manager Devarapalli Devi Prasad | Pending |
To see the full case history of Wallace Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wallace Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Wallace Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Wallace Laboratories Private Limited | U33112GA1996PTC002077 |
To see the full group structure of Wallace Pharmaceuticals Private Limited, buy the company report.
Employees & EPFO
Wallace Pharmaceuticals Private Limited has a workforce of 1,788 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Wallace Pharmaceuticals has 29 GST registrations: 23 active and 6 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 30AAACW1667Q1Z1 | Goa | Active | 01 Jul 2017 |
| 02AAACW1667Q2ZZ | Himachal Pradesh | Active | 01 Jul 2017 |
| 03AAACW1667Q1ZY | Punjab | Active | 01 Jul 2017 |
| 07AAACW1667Q1ZQ | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Wallace Pharmaceuticals Private Limited, buy the company report.
Recent activity
Wallace Pharmaceuticals Private Limited has 21 board changes on record since 1997: 8 appointments and 13 cessations. The latest: Rajashekhar Rayanagoudar Basanagouda was appointed as Whole-Time Director on 01 Feb 2025.
47 earlier events are in the company report.
Frequently asked questions
Wallace Pharmaceuticals is an active private limited company based in Goa, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 February 1968 (58+ years old) and is registered under CIN U24239GA1968PTC000080.
Wallace Pharmaceuticals has 7 current directors:
- Rashmi Menezes - Managing Director
- Cesar Mauricio Jose De Menezes - Managing Director
- Rajashekhar Rayanagoudar Basanagouda - Whole-Time Director
- Sandeep Inamdar - Whole-Time Director
- Vinay Pinto - Director
- Pankaj Kumar - Director
- Maria Emilia Dias Menezes - Director
The latest financial statements of Wallace Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 29 October 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Wallace Pharmaceuticals is 30AAACW1667Q1Z1, registered in Goa. The company has 29 GST registrations in all, of which 23 are active and 6 are cancelled or inactive. Other active GSTINs include 02AAACW1667Q2ZZ (Himachal Pradesh), 03AAACW1667Q1ZY (Punjab), 07AAACW1667Q1ZQ (Delhi).
The CIN (Corporate Identification Number) of Wallace Pharmaceuticals is U24239GA1968PTC000080. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wallace Pharmaceuticals has 161 court cases on record: 112 filed by the company and 51 filed against it. 47 are pending. Most are in the high courts.
Wallace Pharmaceuticals was incorporated on 02 February 1968, making it 58+ years old. It is registered with the Registrar of Companies, Goa.
Wallace Pharmaceuticals has 5 deals on record (5 secondary share transfers); the latest was in March 2019.
The peers of Wallace Pharmaceuticals by revenue are Pritam International Private Limited, Indchemie Health Specialities Private Limited, Sanofi-Synthelabo (India) Private Limited, Apotex Research Private Limited, Servier India Private Limited and 4 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajashekhar Rayanagoudar Basanagouda was appointed as Whole-Time Director on 01 Feb 2025. Rajashekhar Rayanagoudar Basanagouda ceased to be Additional Director on 01 Feb 2025. Sandeep Inamdar was appointed as Whole-Time Director on 01 Feb 2025. Wallace Pharmaceuticals has 21 board changes on record in total.
Wallace Pharmaceuticals can be reached through the website wallacepharma.com. Its registered office is in Goa, India.